Rodman and Renshaw News

After Fresenius reportedly improperly disclosed an elevated risk of cardiac arrest and death during therapy associated with the company's dialysis buffer concentrate product, Rodman & Renshaw believes that the report may highlight the benefits of Rockwell's citrate-based buffer, CitraPure.

S&W SEED COMPANY ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK May 21, 2012 Source: S&W Seed Company news release S&W Seed Company today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a price to the public of $5.50 per share.

's stock had its "outperform" rating reiterated by investment analysts at Rodman & Renshaw in a note issued to investors on Friday.

The sale of S&W Seed ordinary stock will be made within the company's effective shelf registration statement.

The firm currently has an "outperform" rating on the stock. Shares of Pharmacyclics opened at 29.31 on Thursday.

Q&A: Henry Michaels and Jerry Wiant, co-heads of RBC Capital Markets FIG - Friday, May 11, 2012 10:36 AM Following a review of its strategy and business model for the DirectMarkets platform - an automated electronic transaction platform that will directly link existing public company issuers and investors seeking to transact primary offerings of ... (more)

Rodman & Renshaw Capital Group, Inc. will report its first quarter 2012 financial results and provide a business update on the morning of Tuesday, May 15, 2012.

Shares of Retalix Ltd opened at 20.29 on Thursday. Retalix Ltd has a 52 week low of $11.63 and a 52 week high of $21.00. The company has a market cap of $496.8 million and a P/E ratio of 36.89. Separately, analysts at JMP Securities raised their price target on shares of Retalix Ltd from $18.00 to $20.00 in a research note to investors on ... (more)

The firm currently has a $43.00 target price on the stock. Shares of Powell Inds opened at 33.57 on Thursday.

The firm currently has an "outperform" rating on the stock. NPO has been the subject of a number of other recent research reports.